PTGX
Protagonist Therapeutics Inc.
$64.51
+$2.31(+3.71%)
37
Overall
35
Value
40
Tech
--
Quality
Market Cap
$3.64B
Volume
702.60K
52W Range
$33.31 - $63.30
Target Price
$69.69
Key Metrics Overview
| Market Cap | $3.64B | P/E Ratio | N/A |
| 52W High | $63.30 | 52W Low | $33.31 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 54.0% | 52W Position | 104.0% |
| Overall Score | 37 | Value Score | 35 |
| Quality Score | -- | Technical Score | 40 |
Growth Analysis
| EPS Current Est | $-1.86 | EPS Next Est | $0.08 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PTGX | $64.51 | +3.7% | 702.60K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Protagonist Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW